FDA Approves Drug for Neuropathy Pain

Pfizer, Inc., announced on September 21, 2005,that Lyrica (pregabalin) capsules are nowavailable for the management of neuropathicpain associated with diabetic peripheralneuropathy (DPN), postherpetic neuralgia(PHN) and adjunctive treatment of partialonset seizures in adults with epilepsy.

“Until now, we’ve had limited options to treatpatients with these types of neuropathicpain,” says Edgar Ross, MD, director of the PainManagement Center at Brigham and Women’sHospital in Boston. “I have seen the benefitsof Lyrica in providing rapid and sustained painrelief among my patients in the clinical trials.”

According to Pfizer, Lyrica is the firsttreatment approved by the U.S. Food andDrug Administration to treat two distinctforms of neuropathic pain and is the first newantiepileptic drug introduced in five years.

Lyrica is available in pharmacies nationwide. For more information, log on towww.lyrica.com.

Source: Pfizer, Inc.

What Is Neuropathic Pain?

Neuropathic pain is caused bynerve damage that can resultfrom underlying conditions, suchas diabetes or shingles. Nearlyhalf of the 18 million Americanswith diabetes will develop someform of diabetic neuropathy overthe course of their disease andwill suffer from neuropathic pain.

Source: Pfizer, Inc.

Side Effects of Lyrica

The most common side effects ofLyrica are dizziness, sleepiness,dry mouth, swelling of handsand feet, blurred vision, weightgain and trouble concentrating.Patients with a history of drug oralcohol abuse may have a higherchance of misuse or abuse ofLyrica.

Source: Pfizer, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.